Due to its regulatory role in the immune response signaling pathway, Ptprc is also used as a target for treating certain immune diseases, such as organ transplant rejection and tumor metastasis, by selectively inhibiting Ptprc (31, 32). This evidence concerns the gene PTPRC and immune system disorder.